BMP2 and neoplasm: Reduced BMP2 was evident in T3 and T4 tumours of the Luminal B subtype, in comparison with T1 and T2 tumours and the reduced expression was associated with poor overall survival in Luminal B subtype breast cancers (Figures 10A, B).